Laserfiche WebLink
HHS a artrnent of Hogith and Human Servi s - The Department of Health and Human Services <br />or any designee of the Secretary, Department of Health and Human Services. <br />Initial rui test(also known s a "Screening #1VSJgs'J - The test used to differentiate a <br />negative specimen from one that requires further testing for drugs or drug metabolites. <br />ni l i speggimen v lidl test - The first test used to determine if a urine specimen is adulterated, <br />diluted, substituted, or invalid. <br />fall -The result reported by an HHS-certified laboratory in accordance with the criteria <br />established by HHS Mandatory Guidelines when a positive, negative, adulterated, or substituted <br />result cannot be established for a specific drug or specimen validity test. <br />brates -Any U.S. laboratory certified by HHS under the National Laboratory Certification <br />Program as meeting the minimum standards of Subpart C of the HHS Mandatory Guidelines for <br />Federal Workplace Drug Testing Programs; or, in the case of foreign laboratories, a laboratory <br />approved for participation by DOT under this part. <br />Llmft gf Deloglion l] - The lowest concentration at which a measurand can be identified, but (for <br />quantitative assays) the concentration cannot be accurately calculated. <br />LIMft of g11MntI_WloLi- For quantitative assays, the lowest concentration at which the identity and <br />concentration of the measurand can be accurately established. <br />MShccal Review Officer J MPIR4) - A person who is a licensed physician and who is responsible for <br />receiving and reviewing laboratory results generated by an employer's drug testing program and <br />evaluating medical explanations for certain drug test results. <br />Nertative result -The result reported by an HHS-certified laboratory to an MRO when a specimen <br />contains no drug or the concentration of the drug is less than the cutoff concentration for the drug or <br />drug class and the specimen is a valid specimen. <br />Non-1]2gative 129&IM,20,7A urine specimen that is reported as adulterated, substituted, positive (for <br />drug(s) or drug metabolite(s)), and/or invalid. <br />- The office in the Office of the <br />Secretary, DOT, that is responsible for coordinating drug and alcohol testing program matters within <br />the Department and providing information conceming the implementation of Part 40. <br />.Opgr -A person who owns or operates pipeline facilities subject to 49 CFR Part 192, 193, or <br />195. <br />fix Izinci adulterant - A substance that acts alone or in combination with other substances to <br />oxidize drugs or drug metabolites to prevent the detection of the drug or drug metabolites, or affects <br />the reagents in either the initial or confirmatory drug test. <br />Performs a gw%4 f n - Actually performing, ready to perform, or immediately available to <br />perform a covered function. <br />Pipeline - All parts of those physical facilities through which gas, hazardous liquids or carbon dioxide <br />moves in transportation, including, but limited to, pipe, valves, and other appurtenance attached to <br />pipe, compressor units, metering stations, regulator stations, delivery stations, holders, pumping <br />units, breakout tanks and fabricated assemblies. <br />PiRgline fcility - New and existing pipelines, rights -of -way, and any equipment, facility, or building <br />used in the transportation of gas or in the treatment of gas, or transportation of hazardous liquids or <br />carbon dioxide during the course of transportation. <br />Positive to for random dru tlestin -The number of verified positive results for random drug <br />tests conducted under Part 199, plus the number of refusals of random drug tests required by Pert <br />199, divided by the total number of random drug tests conducted plus the number of refusals of <br />random tests under Part 199. <br />J. RANCK ELECTRIC, INC. <br />PHMSA DRUG/ALCOHOL PLAN <br />NATIONAL COMPI LANCE MANAGEMENT SERVICE, INC (NCMS) ^ 2010 10 <br />